Clinical Trial Details
— Status: Not yet recruiting
Administrative data
NCT number |
NCT06358781 |
Other study ID # |
xuyajun197673-002 |
Secondary ID |
|
Status |
Not yet recruiting |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
April 22, 2024 |
Est. completion date |
June 30, 2024 |
Study information
Verified date |
April 2024 |
Source |
Peking University |
Contact |
Yunjia Yang |
Phone |
13718132924 |
Email |
greendayang[@]163.com |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
Dose-response validation of whole grain dietary intake biomarkers remains limited, and it is
debatable whether these markers could be utilized as classifiers for different levels of
whole grain consumption. Because there are significant disparities in genetic background and
dietary patterns between Chinese and Western cultures, it is unclear if whole grain dietary
intake biomarkers can characterize whole grain consumption in Chinese populations. To address
these issues, the current study was designed to evaluate the sensitivity and specificity of
potential whole grain markers in a randomized controlled trial, as well as to validate the
markers' dose-response relationship, so that they can be used in nutritional epidemiological
studies and dietary intake assessments of whole grains.
Description:
An acute randomized controlled trial was performed and the total study group is randomly
divided into four groups: the amounts of WG wheat flour administered were 0 g, 25g, 50 g and
100 g. Experimental period with a total of 6 days was subdivided into two parts: -5 days to 0
h defined as the run-in period, 0-24 h (after the dose-related test meal), defined as the
test day.